thetaOwl

MSTR

Strategy IncClose $123.97EOD only
Max Pain
$129.00
Next expiry Jun 18, 2026
Expected Move
±$9.62
7.8% from close
Price Gap
+5.03
Distance to max pain
IV Rank
100
High premium
P/C OI
0.95
Balanced positioning
Consensus
6.5/10
Neutral tilt
Published snapshot: Jun 12, 2026 close
End-of-day snapshot

This page reflects MSTR options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
Jun 12, 2026 close
MSTR AI Consensus Report
Analysis based on market close June 12, 2026

Historical consensus-supported lens with full content, report chain context, and metric rail.

Conviction
6.5

out of 10

6.5 not 7.5 because flow's bullish positioning could break the pin and resistance, creating a directional conflict that reduces conviction; also earnings event in 48 days adds uncertainty.

Where Perspectives Agree

Neutral-bullish pin near $125 with support from GEX and positive gamma, but capped near $130 by resistance and call walls.

Where They Diverge

Flow shows heavy call buying at $135-139 suggesting upside breakout beyond resistance, contradicting the pin and capped thesis from directional and theta perspectives.

Top Trade
via directional

Sell MSTR 2026-08-21 $120/$115 put spread for $2.10 credit

Key Risk

Break below $120 flips dealer gamma long and triggers stop-loss cascade; downside accelerates to $115 and potentially $100.

How to Use These Reports
This ai consensus reflects the market close on June 12, 2026.
What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.